Evidence map›Paper›PMID 33104884›Full record

ReviewJournal of cancer research and clinical oncology2020

Penile cancer: a Brazilian consensus statement for low- and middle-income countries.

Andrey Soares, Icaro Thiago de Carvalho, Aluízio Gonçalves da Fonseca, Antonio Machado Alencar, Carlos Heli Bezerra Leite, Diogo Assed Bastos, João Paulo Holanda Soares, Katia Ramos Moreira Leite, Mário Ronalsa Brandão Filho, Ronald Wagner Pereira Coelho and 3 more

Open access · hybridAbstract readReviewConsensus Statement
In one paragraph

Review in Journal of cancer research and clinical oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Epidemiological study of penile cancer in a northeastern state - Brazil.Revista do Colegio Brasileiro de Cirurgioes · 2023
    Article
  5. Article
  6. Article
  7. Article
  8. Living in a rural area as a risk factor for worst outcomes in penile cancer.International braz j urol : official journal of the Brazilian Society of Urology
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 8 institutions in 2 countries.

Andrey SoaresDepartment of Oncology, Centro Paulista de Oncologia-Oncoclínicas, Av. Brigadeiro Faria Lima, 4300, Vila Olímpia, São Paulo, SP, 01452-000, Brazil. dr.andrey@uol.com.br.ORCID http://orcid.org/0000-0003-4980-6729
Icaro Thiago de CarvalhoDepartment of Radiotherapy, Hospital Israelita Albert Einstein, São Paulo, São Paulo, Brazil.ORCID http://orcid.org/0000-0003-0607-7589
Aluízio Gonçalves da FonsecaDepartment of Urology, Hospital Ophir Loyola, Belém, Pará, Brazil.
Antonio Machado AlencarDepartment of Oncology, Hospital Universitário da Universidade Federal do Maranhão, São Luís, Maranhão, Brazil.
Carlos Heli Bezerra LeiteDepartment of Radiotherapy, Hospital Haroldo Juaçaba, Fortaleza, Ceará, Brazil.ORCID http://orcid.org/0000-0003-2161-0222
Diogo Assed BastosLatin American Cooperative Oncology Group, Porto Alegre, Rio Grande do Sul, Brazil.
João Paulo Holanda SoaresDepartment of Oncology, Hospital Haroldo Juaçaba, Fortaleza, Ceará, Brazil.
Katia Ramos Moreira LeiteMedical Research Laboratory of the Discipline of Urology, Faculdade de Medicina da USP, São Paulo, São Paulo, Brazil.ORCID http://orcid.org/0000-0002-2615-7730
Mário Ronalsa Brandão FilhoDepartment of Urology, Santa Casa de Misericórdia de Maceió, Maceió, Alagoas, Brazil.
Ronald Wagner Pereira CoelhoLatin American Cooperative Oncology Group, Porto Alegre, Rio Grande do Sul, Brazil.
Sandro Roberto de A CavalleroLatin American Cooperative Oncology Group, Porto Alegre, Rio Grande do Sul, Brazil.
Stênio de Cassio ZequiDepartment of Urology, AC Camargo Cancer Center, São Paulo, São Paulo, Brazil.
José de Ribamar Rodrigues CalixtoDepartment of Urology, Hospital Universitário Presidente Dutra, UFMA, São Luís, Maranhão, Brazil.
Hospital Haroldo Juaçaba · BRHospital Israelita Albert Einstein · BRHospital Universitário da Universidade Federal do Maranhão · BRAC Camargo Hospital · BRFundação de Amparo à Pesquisa e ao Desenvolvimento Científico e Tecnológico do Maranhão · BRHospital Sírio-Libanês · BRSanta Casa de Misericórdia de Marília · BRUniversidade do Estado do Pará · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposePenile cancer is highly prevalent in low- and middle-income countries, with significant morbidity and mortality rates. The first Brazilian consensus provides support to improve penile cancer patients' outcomes, based on expert's opinion and evidence from medical literature.

methodsFifty-one Brazilian experts (clinical oncologists, radiation oncologists, urologists, and pathologists) assembled and voted 104 multiple-choice questions, confronted the results with the literature, and ranked the levels of evidence.

resultsHealthcare professionals need to deliver more effective communication about the risk factors for penile cancer. Staging and follow-up of patients include physical examination, computed tomography, and magnetic resonance imaging. Close monitoring is crucial, because most recurrences occur in the first 2-5 years. Lymph-node involvement is the most important predictive factor for survival, and management depends on the location (inguinal or pelvic) and the number of lymph nodes involved. Conservative treatment may be helpful in selected patients without compromising oncological outcomes; however, surgery yields the lowest rate of local recurrence.

conclusionThis consensus provides an essential decision-making orientation regarding this challenging disease.

Indexed as

Developing CountriesBrazilHumansLymphatic MetastasisLymph NodesMaleNeoplasm Recurrence, LocalPenile NeoplasmsRisk FactorsCancer consensusHPV cancer-relatedPenile cancerUrologic malignancy

Identifiers

PMID33104884
PMCPMC7679332
OpenAlexW3094403665

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.